Dermatofibrosarcoma protuberans;Dermatofibrosarcoma protuberans

Actas Dermo-Sifiliograficas

Volumn 98, Issue 2, 2007, Pages 77-87

  Sanmartín Jiménez, Onofre ^a   Llombart, B ^a   Lopez Guerrero J A ^a   Serra, C ^a   Requena, C ^a   Guillen C ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

COL1A1 PDGFB; Dermatofibrosarcoma protuberans; Imatinib; Mohs surgery; RT PCR

Indexed keywords

BCR ABL PROTEIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ADVANCED CANCER; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; CYTOGENETICS; DERMATOFIBROSARCOMA PROTUBERANS; EXCISION; HUMAN; IMMUNOHISTOCHEMISTRY; MORBIDITY; PREVALENCE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOFT TISSUE SARCOMA; SURGICAL TECHNIQUE;

EID: 34248154837     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70019-4     Document Type: Review

References (68)

1. Darier J, Ferrand M. Dermatofibromes progressifs et recidivants ou fibrosarcomes de la peau. Ann Dermatol Syphiligr (Paris). 1924;5:542-62.
2. Hoffman E. Ueber das knollentribende fibrosarkam der haut (dermatofibrosarcoma protuberans). Dermatol Z. 1925;43: 1-28.
3. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer. 1962;15:717-25.
4. Altman DA, Nickoloff BJ, Fivenson DP. Dermatofibrosarcoma protuberans strongly express CD34 (abstract). J Cutan Pathol. 1992;19:509.
5. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993;15:429-34.
6. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet. 1997;15:95-8.
7. Llombart B, Sanmartín O, López-Guerrero J. Dermatofibrosarcoma protuberante en la infancia. Piel. 2006;21: 435-41.
8. Bendix-Hansen K, Myhre-Jensen O, Kaae S. Dermatofibrosarcoma protuberans. A clinico-pathological study of nineteen cases and review of world literature. Scand J Plast Reconstr Surg. 1983;17:247-52.
9. Chuang T-Y SW, Muller SA. Incidence of cutaneous T cell lymphoma and other rare skin tumors in a defined population. J Am Acad Dermatol. 1990;23:254-6.
10. Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2006.
11. Gloster HM, Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:355-74; quiz 75-6.
12. Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol. 1985;9:630-9.
13. Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzar E. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol. 1992;18:241-8.
14. Annessi G, Cimitan A, Girolomoni G, DiSilveiro A. Congenital dermatofibrosarcoma protuberans. Pediatr Dermatol. 1993;10: 40-2.
15. McKee PH, Fletcher CD. Dermatofibrosarcoma protuberans presenting in infancy and childhood. J Cutan Pathol. 1991;18:241-6.
16. Checketts SR, Hamilton TK, Baughman RD. Congenital and childhood dermatofibrosarcoma protuberans: a case report and review of the literature. J Am Acad Dermatol. 2000;42:907-13.
17. Martin L, Combemale P, Dupin M, Chouvet B, Kanitakis J, Bouyssou-Gauthier ML, et al. The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol. 1998;139:719-25.
18. Fletcher CD. Giant cell fibroblastoma of soft tissue: a clinicopathological and immunohistochemical study. Histopathology. 1988;13:499-508.
19. Shmookler BM, Enzinger FM, Weiss SW. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer. 1989;64:2154-61.
20. Billings SD, Folpe AL. Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy: an update. Am J Dermatopathol. 2004;26:141-55.
21. Pearce MS, Parker L, Cotterill SJ, Gordon PM, Craft AW. Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK. Melanoma Res. 2003;13: 421-6.
22. Barnes L, Coleman JA, Jr., Johnson JT. Dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol. 1984; 110: 398-404.
23. Mbonde MP, Amir H, Kitinya JN. Dermatofibrosarcoma protuberans: a clinicopathological study in an African population. East Aft Med J. 1996;73:410-3.
24. Bashara ME, Jules KT, Potter GK. Dermatofibrosarcoma protuberans: 4 years after local trauma. J Foot Surg. 1992;31: 160-5.
25. Tanaka A, Hatoko M, Tada H, Kuwahara M, Iioka H, Niitsuma K. Dermatofibrosarcoma protuberans arising from a burn scar of the axilla. Ann Plast Surg. 2004;52:423-5.
26. Argiris A, Dardoufas C, Aroni K. Radiotherapy induced soft tissue sarcoma: an unusual case of a dermatofibrosarcoma protuberans. Clin Oncol (R Coll Radiol). 1995;7:59-61.
27. Green JJ, Heymann WR. Dermatofibrosarcoma protuberans occurring in a smallpox vaccination scar. J Am Acad Dermatol. 2003;48:S54-5.
28. Bukhari I, Al Akloby O, Bedaiwi Y. Dermatofibrosarcoma protuberans at the site of a central venous line. Case report. Am J Clin Dermatol. 2005;6:61-4.
29. Kim SD, Park JY, Choi WS, Kim SH, Lim DJ, Chung HS. Intracranial recurrence of the scalp dermatofibrosarcoma. Clin Neurol Neurosurg. 2006.
30. Loss L, Zeitouni NC. Management of scalp dermatofibrosarcoma protuberans. Dermatol Surg. 2005;31:1428-33.
31. Rabinowitz LG, Luchetti ME, Segura AD, Esterly NB. Acrally occurring dermatofibrosarcoma protuberans in children and adults. J Dermatol Surg Oncol. 1994;20:655-9.
32. Martin L, Piette F, Blanc P, Mortier L, Avril MF, Delaunay MM, et al. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol. 2005;153:932-6.
33. Kamino H, Jacobson M. Dermatofibroma extending into the subcutaneous tissue. Differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol. 1990;14:1156-64.
34. Zelger BW, Ofner D, Zelger BG. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans. Histopathology. 1995;26:519-27.
35. Aiba S, Tabata N, Ishii H, Ootami H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol. 1992;127:79-84.
36. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993;28:613-7.
37. Cowper SE, Kilpatrick T, Proper S, Morgan MB. Solitary fibrous tumor of the skin. Am J Dermatopathol. 1999;21: 213-9.
38. Hanft VN, Shea CR, McNutt NS, Pullitzer D, Horenstein MG, Prieto VG. Expression of CD34 in sclerotic («plywood») fibromas. Am J Dermatopathol. 2000;22:17-21.
39. Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001;32: 704-14.
40. McNiff JM, Subtil A, Cowper SE, Lazova R, Glusac EJ. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans. J Cutan Pathol. 2005;32: 413-8.
41. Diwan AH, Horenstein MG. Dermatofibrosarcoma protuberans association with nuchal-type fibroma. J Cutan Pathol. 2004;31:62-6.
42. Sachdev R, Sundram U. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa. J Cutan Pathol. 2006;33:353-60.
43. Cribier B, Noacco G, Peltre B, Grosshans E. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2002;46:408-13.
44. West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, et al. Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans. Am J Surg Pathol. 2004;28:1063-9.
45. Mentzel T, Beham A, Katenkamp D, DeiTos AP, Fletcher CD. Fibrosarcomatous («high-grade») dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22:576-87.
46. Díaz-Cascajo C, Weyers W, Borrego L, Inarrea JB, Borghi S. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases. Am J Dermatopathol. 1997;19:562-7.
47. Abbott JJ, Oliveira AM, Nascimento AG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol. 2006;30: 436-43.
48. Llombart B, Sanmartín O, López-Guerrero JA, Monteagudo C, Calabuig S, Botella R, et al. [Analysis of the COL1A1-PDGFB fusion gene in a case of dermatofibrosarcoma protuberans with a fibrosarcoma component]. Actas Dermosifiliogr. 2006;97:337-41.
49. Abbott JJ, Erickson-Johnson M, Wang X, Nascimento G, Oliveira AR. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mod Pathol. 2006;19:1512-8.
50. Sheehan DJ, Madkan V, Strickling WA, Peterson CM. Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature. Cutis. 2004;74:237-42.
51. Young CR, 3rd, Albertini MJ. Atrophic dermatofibrosarcoma protuberans: case report, review, and proposed molecular mechanisms. J Am Acad Dermatol. 2003;49:761-4.
52. Sabater-Marco V, Pérez-Valles A, Berzal-Cantalejo F, Rodríguez-Serna M, Martínez-Díaz F, Martorell-Cebollada M. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int J Dermatol. 2006;45:59-62.
53. Sanz-Trelles A, Ayala-Carbonero A, Rodrigo-Fernández I, Weil-Lara B. Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans. J Cutan Pathol. 1998;25:44-9.
54. Banerjee SS, Harris M, Eyden BP, Hamid BN. Granular cell variant of dermatofibrosarcoma protuberans. Histopathology. 1990; 17:375-8.
55. Bridge JA, Neff JR, Sandberg AA. Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990;49:199-202.
56. Pedeutour F, Coindre JM, Sozzi G, Nicolo G, Leroux A, Toma S, et al. Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet. 1994;76: 1-9.
57. Pedeutour F, Simon MP, Minoletti F, Sozzi G, Pierotti MA, Hecht F, et al. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res. 1995;55:2400-3.
58. Minoletti F, Miozzo M, Pedeutour F, Sard L, Pilotti S, Azzarelli A, et al. Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans. Genes Chromosomes Cancer. 1995;13:62-5.
59. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol. 1995;147:1553-8.
60. Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data - a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2003;27:27-39.
61. Shimizu A, O'Brien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, et al. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 1999;59:3719-23.
62. McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol. 2005;23:866-73.
63. Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23:7669-75.
64. Gloster HM, Jr., Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:82-7.
65. Chang CK, Jacobs IA, Salti GI. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol. 2004; 30:341-5.
66. Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB, et al. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer. 2004;101:28-38.
67. Wacker J, Khan-Durani B, Hartschuh W. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol. 2004; 11:438-44.
68. McArthur G. Molecularly targeted treatment for dermatofibrosarcoma protuberans. Semin Oncol. 2004;31:30-6.